HS9in7wFk5ZUyrCuvYva

(GMCR, STEM, DSCO) CRWENewswire Stocks In Action

  • 0
  • 0

StemCells Inc - STEM - reported that the FDA has authorized the initiation of a Phase I/II clinical trial of the Company’s proprietary HuCNS-SC product candidate (purified human neural stem cells) in dry age-related macular degeneration

02 Feb 2012

83 Visualizações

dsco, gmcr, stem

Estatísticas do vídeo

Mostrar:

Comentários

Vídeos em Destaque